David H. Persing, Executive VP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 10,000 shares at $45.69 ($455K) on 2012-07-02, disclosed to the SEC on 2012-07-03.
Scheduled sale ($455k) by Executive VP, Chief Med/Tech Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.23 | 5,000 | $226K | 49.7% |
| 2 | $45.69 | 5,000 | $228K | 50.3% |
| Total | $45.46 avg | 10,000 | $455K | 100% |
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |